作者
Silvia Rivara, Alessio Lodola, Marco Mor, Annalida Bedini, Gilberto Spadoni, Valeria Lucini, Marilou Pannacci, Franco Fraschini, Francesco Scaglione, Rafael Ochoa Sanchez, Gabriella Gobbi, Giorgio Tarzia
发表日期
2007/12/27
期刊
Journal of medicinal chemistry
卷号
50
期号
26
页码范围
6618-6626
出版商
American Chemical Society
简介
A novel series of melatonin receptor ligands, characterized by a N-(substituted-anilinoethyl)amido scaffold, along with preliminary structure–activity relationships (SARs), is presented. MT1 and MT2 receptor binding affinity and intrinsic activity have been modulated by the introduction of different substituents on the aniline nitrogen, on the benzene ring, and on the amide side chain. Modulation of intrinsic activity and MT2 selectivity of the newly synthesized compounds has been achieved by applying SAR models previously developed, providing compounds with different binding and intrinsic activity profiles. Compound 3d, with a bulky ß-naphthyl group, behaves as an MT2-selective antagonist with sub-nM affinity. Size reduction of the substituent enhances intrinsic activity, as in the nonselective N-methyl-anilino agonist 3i. The phenyl derivative 3g is an MT2-selective partial agonist, with MT2 binding affinity higher …
引用总数
200820092010201120122013201420152016201720182019202020212022202320243751296126636157633